Invention Grant
US07790749B2 Use of pleuromutilins for the treatment of disorders caused by Helicobacter pylori
有权
使用pleuromutilins治疗由幽门螺杆菌引起的疾病
- Patent Title: Use of pleuromutilins for the treatment of disorders caused by Helicobacter pylori
- Patent Title (中): 使用pleuromutilins治疗由幽门螺杆菌引起的疾病
-
Application No.: US10510532Application Date: 2003-04-22
-
Publication No.: US07790749B2Publication Date: 2010-09-07
- Inventor: Gerd Ascher , Johannes Hildebrandt
- Applicant: Gerd Ascher , Johannes Hildebrandt
- Applicant Address: AT Vienna
- Assignee: Nabriva Therapeutics AG
- Current Assignee: Nabriva Therapeutics AG
- Current Assignee Address: AT Vienna
- Agent D. Peter Hochberg; Sean F. Mellino; Daniel J. Smola
- Priority: GB0209262.5 20020423
- International Application: PCT/EP03/04173 WO 20030422
- International Announcement: WO03/090740 WO 20031106
- Main IPC: A01N43/40
- IPC: A01N43/40 ; A01N33/00 ; A01N47/28
Abstract:
A method of preventing or treating diseases mediated by Helicobacter pylori, comprising administering to a subject in need of such treatment an effective amount of pleuromutilin.
Public/Granted literature
- US20050131023A1 Use of pleuromutilins for the treatment of disorders caused by helicobacter pylori Public/Granted day:2005-06-16
Information query
IPC分类:
